[Tobacco smoking among hospitalised patients with coronary arterial disease]

Izabella Kara1, Monika Zysnarska, Monika Borkowicz

  • 1Zakład Zdrowia Publicznego, Katedra Medycyny Społecznej, Uniwersytet Medyczny im. Karola Marcinkowskiego, Poznań. zdrowiepubliczne@ump.edu.pl

Przeglad Lekarski
|March 23, 2010
PubMed

Insights

Despite knowing the severe health risks, a significant number of coronary arterial disease (CAD) patients continue to smoke. Awareness of smoking

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Context:

  • Cardiovascular diseases, including coronary arterial disease (CAD), are a major global health concern.
  • Tobacco smoking is a leading preventable risk factor for cardiovascular diseases.
  • The prevalence of smoking remains high, particularly in certain populations like Poland.

Purpose:

  • To investigate the relationship between tobacco smoking and coronary arterial disease (CAD) in a Polish patient cohort.
  • To assess the awareness of smoking's negative health impacts among CAD patients.
  • To examine the lifestyle behaviors, including smoking status, of hospitalized CAD patients.

Summary:

  • A study of 100 hospitalized CAD patients in Poland revealed that 17% were current smokers, 56% had quit, and 27% had never smoked.
  • Nearly all patients (97%) were aware of the detrimental effects of smoking on health.
  • The realization that smoking influenced CAD progression was a key factor for 56% of patients who quit smoking.

Impact:

  • Highlights a significant discrepancy between awareness of smoking's harms and actual smoking behavior among CAD patients.
  • Underscores the need for targeted smoking cessation interventions in cardiovascular patient populations.
  • Informs public health strategies aimed at reducing smoking prevalence and its associated cardiovascular burden.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...